DAPAGLIFLOZIN MODULATES ADROPIN SERUM LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE

被引：0
|
作者：
Berezin, Alexander [1 ]
Fushtey, Ivan M. [2 ]
Berezin, Alexander A. [2 ]
机构：
[1] State Med Univ, Dept Internal Med, Zaporozhe, Ukraine
[2] Med Acad Postgrad Educ, Dept Internal Med, Zaporozhe, Ukraine
来源：
JOURNAL OF HYPERTENSION | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
下载
收藏
页码：E100 / E100
页数：1
相关论文
共 50 条
  • [41] Serum and salivary ferritin and Hepcidin levels in patients with chronic periodontitis and type 2 diabetes mellitus
    Lin-Na Guo
    Yan-Zong Yang
    Yun-Zhi Feng
    BMC Oral Health, 18
  • [42] Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure
    Tanaka, H.
    Soga, F.
    Tatsumi, K.
    Mochizuki, Y.
    Sano, H.
    Toki, H.
    Matsumoto, K.
    Shite, J.
    Takaoka, H.
    Doi, T.
    Hirata, K.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1009 - 1009
  • [43] Serum and salivary ferritin and Hepcidin levels in patients with chronic periodontitis and type 2 diabetes mellitus
    Guo, Lin-Na
    Yang, Yan-Zong
    Feng, Yun-Zhi
    BMC ORAL HEALTH, 2018, 18
  • [44] Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure
    Hidekazu Tanaka
    Fumitaka Soga
    Kazuhiro Tatsumi
    Yasuhide Mochizuki
    Hiroyuki Sano
    Hiromi Toki
    Kensuke Matsumoto
    Junya Shite
    Hideyuki Takaoka
    Tomofumi Doi
    Ken-ichi Hirata
    Cardiovascular Diabetology, 19
  • [45] Interrelation between adropin and severity of heart failure in hypertensive patients with diabetes mellitus and obesity
    Shelest, B. Borys
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 59 - 59
  • [46] Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure
    Tetiana A. Berezina
    Ivan M. Fushtey
    Alexander A. Berezin
    Sergii V. Pavlov
    Alexander E. Berezin
    Advances in Therapy, 2024, 41 : 292 - 314
  • [47] Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure
    Berezina, Tetiana A.
    Fushtey, Ivan M.
    Berezin, Alexander A.
    Pavlov, Sergii V.
    Berezin, Alexander E.
    ADVANCES IN THERAPY, 2024, 41 (01) : 292 - 314
  • [48] Clinical Significance of Skin Autofluorescence in Patients With Type 2 Diabetes Mellitus With Chronic Heart Failure
    Hitsumoto, Takashi
    CARDIOLOGY RESEARCH, 2018, 9 (02) : 83 - 89
  • [49] EFFECT OF GLYCAEMIC CONTROL ON OUTCOME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE
    Lang, Chim C.
    Levin, Daniel
    Mohan, Mohapradeep
    Parry, Helen
    Elder, Douglas
    Struthers, Allan D.
    Choy, Anna Maria
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A886 - A886
  • [50] Improving outcomes in patients with type 2 diabetes mellitus and chronic heart failure: New hope
    Kearney, Mark
    JOURNAL OF DIABETES, 2018, 10 (10) : 799 - 800
12345